[Clinical and laboratory investigation of pefloxacin used prophylactically in operations on the liver].
Khlebnikov
E P
EP
Vishnevskiĭ
V A
VA
Kubyshkin
V A
VA
Terekhova
R P
RP
D000328:Adult; D000368:Aged; D000890:Anti-Infective Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D001424:Bacterial Infections / Q000382:microbiology / Q000517:prevention & control*; D004444:Echinococcosis, Hepatic / Q000601:surgery; D005260:Female; D005658:Fungi / Q000302:isolation & purification; D006090:Gram-Negative Bacteria / Q000302:isolation & purification; D006094:Gram-Positive Bacteria / Q000302:isolation & purification; D006801:Humans; D007275:Injections, Intravenous; D008107:Liver Diseases / Q000601:surgery*; D008113:Liver Neoplasms / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000382:microbiology / Q000517:prevention & control*; D015366:Pefloxacin / Q000008:administration & dosage* / Q000493:pharmacokinetics; D011183:Postoperative Complications / Q000382:microbiology* / Q000517:prevention & control*; D016896:Treatment Outcome
D000890:Anti-Infective Agents; D015366:Pefloxacin